Business Segments · Other adjustments
North American Pharmaceutical — Other adjustments
Year-over-year, this metric declined by 100.0%, from $1.25M to $0.00. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryProfitability
SignalLower is better
VolatilityModerate
First reportedQ2 2024
Last reportedQ1 2026
How to read this metric
Frequent or large adjustments suggest high operational volatility or ongoing restructuring efforts that may obscure core segment profitability.
Detailed definition
Various non-recurring or non-operational adjustments applied to the North American pharmaceutical segment's financial re...
Peer comparison
Standard practice for companies to provide 'adjusted' segment metrics to normalize performance for investors.
Metric ID:
mck_segment_north_american_pharmaceutical_other_adjustmentsHistorical Data
2 years
| FY'25 | FY'26 | |
|---|---|---|
| Value | $5.00M | $0.00 |
| YoY Change | — | -100.0% |
Range$0.00 – $5.00M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's north american pharmaceutical — other adjustments?
- McKesson (MCK) reported north american pharmaceutical — other adjustments of $0.00 in Q1 2026.
- How has McKesson's north american pharmaceutical — other adjustments changed year-over-year?
- McKesson's north american pharmaceutical — other adjustments decreased by 100.0% year-over-year, from $1.25M to $0.00.
- What does north american pharmaceutical — other adjustments mean?
- Non-recurring or special accounting adjustments affecting the reported performance of the pharmaceutical segment.